Me. Villarino et al., Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection, J AM MED A, 281(2), 1999, pp. 169-171
Citations number
12
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Context One or both commercial tuberculin skin test reagents (Aplisol and T
ubersol) may have a high rate of false-positive reactions.
Objective To compare the reaction size and specificity of skin testing with
Aplisol, Tubersol, and the standard purified protein derivative (PPD-S1),
Design Double-blind trial, conducted between May 14, 1997, and October 28,
1997, in which each individual received 4 tuberculin skin reagents at sites
assigned at random.
Setting Health departments and universities in 6 US cities.
Participants A total of 1555 persons at low risk of latent tuberculosis inf
ection.
Intervention Simultaneous skin tests with Aplisol, Tubersol, PPD-S1, and ei
ther a second PPD-S1 or PPD-S2 (a proposed new standard).
Main Outcome Measure Reaction size at each injection site measured by 2 inv
estigators blinded to type of reagent.
Results Aplisol produced slightly larger reactions than Tubersol, but this
difference did not significantly change skin test interpretation. The mean
+/- SD reaction sizes were 3.4 +/- 4.2 mm with Aplisol, 2.1 +/- 3.2 mm with
Tubersol, and 2.5 +/- 3.6 mm with PPD-S1. Assuming that all participants w
ere uninfected and using a 10-mm cutoff, the specificities of the tests wer
e high: Aplisol, 98.2%; Tubersol, 99.2%; and PPD-S1, 98.9%, Significant var
iability was not detected in interobserver, host, and lot-to-lot reagent co
mparisons.
Conclusion Using a cutoff of at least 10 mm, testing with 3 different PPD r
eagents resulted in similar numbers of uninfected persons being correctly c
lassified.